Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells.
about
Macrocyclic histone deacetylase inhibitorsTargeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsHistone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancyAberrant histone acetylation promotes mitochondrial respiratory suppression in the brain of alcoholic rats.The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells.Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells.Histone deacetylases 9 and 10 are required for homologous recombination.Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells.Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents.Histone deacetylase inhibitors in clinical development.Lead Induces Apoptosis and Histone Hyperacetylation in Rat Cardiovascular Tissues.Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells.Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatoninHistone deacetylase inhibitors: insights into mechanisms of lethality.Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation.Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activationBCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing.Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms.The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells.Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors.HDAC inhibitors in HIV.Natural products as zinc-dependent histone deacetylase inhibitors.HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review)Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway.Histone Deacetylase Inhibitors as Anticancer Drugs.Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway.Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo.Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells.Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.Immunohistochemical analysis of acetylation, proliferation, mitosis, and apoptosis in tumor xenografts following administration of a histone deacetylase inhibitor--a pilot study.Histone deacetylase inhibitor NVP-LAQ824 has significant activity against myeloid leukemia cells in vitro and in vivo.FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion-induced apoptosis of insulin-secreting cells.Quantitative proteomics reveals a role for epigenetic reprogramming during human monocyte differentiation.Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer CellsRegulation of autophagy by ceramide-CD95-PERK signaling.The in vitro apoptotic effects of A248 and A1659, newly synthetic histone deacetylase inhibitors in oral cancer cells.Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors.Apicidin potentiates the imatinib-induced apoptosis of Bcr-Abl-positive human leukaemia cells by enhancing the activation of mitochondria-dependent caspase cascades.
P2860
Q24629065-2E649C12-FEFF-4D6C-941D-CCB1CCB7B4DCQ26853394-939D1FAB-036B-4FEE-9DC3-6AA20B88393DQ28082536-583BDC0A-204E-4BCC-8CCB-2E6FECD8092CQ30392399-CFD3D492-0826-4D82-B0DF-488BB44C026FQ33757575-158B037C-4E0C-4735-A3E0-BBD1E1F53F27Q34104350-6D208BC8-E68C-46AD-BB59-B60D0B196745Q34624058-95F3B7AB-56CD-452D-AAB5-62B258C3E4D7Q34629026-104BCD55-D9D4-4DA4-B7DA-C1FD071D1035Q35214924-745A2E18-51D0-4FE4-98BA-3C68AA234CA3Q35609717-A5FBF775-40D4-4214-9AE0-9E7F6FEEBE87Q35663628-7523E8A9-AEF0-4305-BDFF-C2825F5614A2Q35739692-B6213DEF-CCC6-4F51-899F-955F845EA786Q35858998-9500F6BB-9ACE-41A4-A855-FAB721B27E6EQ36219726-E5C61EB2-9856-4B75-95CE-79245DF45EF5Q36922674-EF088C7A-1A93-48D6-A2C9-9375B17E3D96Q37172903-8823D9BE-E09D-4DBD-B2FC-0757C37495B3Q37268123-F069CDFC-F74E-4397-84A4-A59EB6554822Q37268127-751D12D7-1E83-44B5-BAC1-33DE12A56BA6Q37427549-C0F092A5-5F04-45C9-9AC3-BB7ABF194A2FQ37524525-D7C4B3C3-1693-4EB6-A8DA-7DE9F51642EBQ37902054-36F3B3E5-1C37-4DC7-9D09-7B30E0B15145Q37956178-0B29B0B7-F913-41C0-B7BD-4A9E26AA94DFQ38315538-BD2A33BD-E0A7-44FB-804A-0793F4BC22F7Q38333926-C0D409B6-9E28-4E10-A0C0-51D560EADCACQ38350788-26302970-00FA-44FA-B18C-36ABEAC6F70DQ38696932-3536EDED-0B9F-4645-9933-471006A81900Q39680200-EE138932-89CD-4B8C-8E74-7FC4666F5D45Q39859377-0FA051BC-D6E4-4BC2-9D47-8832E920F9D3Q40082894-BFAF9918-B539-498C-9BEF-8EA6FAEB6FEBQ40140332-11C0C753-D953-4E3D-873D-75D90378022FQ40334140-B53D62DB-88AF-44A1-8D1D-6C727D0911C4Q40501526-2E76ED71-EAD7-4C5C-9E3F-9A904DB46189Q40612629-63803044-83FF-4DE6-9E81-0165435A0EABQ40635072-120152CD-CF25-4474-BE81-084D83EC6A63Q41700803-46A25D5D-DAA4-4360-A312-5429A4B36965Q42328146-53624905-26D4-48AF-AACE-F80388EE2532Q42613657-F600ED69-72B2-458D-8F24-84B798F8D760Q43970077-3AA1319A-F202-491D-B66A-103EC60B536EQ44321035-3D24F47D-0B4D-4531-814F-707AED9C0CD5Q44700424-955CEFFF-0480-4CCB-B62A-44E81E33D178
P2860
Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Apicidin, a histone deacetylas ...... promyelocytic leukemia cells.
@en
Apicidin, a histone deacetylas ...... promyelocytic leukemia cells.
@nl
type
label
Apicidin, a histone deacetylas ...... promyelocytic leukemia cells.
@en
Apicidin, a histone deacetylas ...... promyelocytic leukemia cells.
@nl
prefLabel
Apicidin, a histone deacetylas ...... promyelocytic leukemia cells.
@en
Apicidin, a histone deacetylas ...... promyelocytic leukemia cells.
@nl
P2093
P2860
P356
P1476
Apicidin, a histone deacetylas ...... promyelocytic leukemia cells.
@en
P2093
Gyu-Un Bae
Hoi Young Lee
Hyang-Woo Lee
Jeung-Whan Han
Jong Woo Yoon
Seong Hoon Ahn
So Hee Kwon
Sungyoul Hong
Yin-Won Lee
Yong Kee Kim
P2860
P304
P356
10.1074/JBC.M106699200
P407
P577
2001-11-06T00:00:00Z